Trial NCT04817345

View at ClinicalTrials.gov 
Org. Study IDs: ASPIRES2

Last trial update was posted on 2023-04-07

MeSH Interventions

Plerixafor

MeSH Conditions

Anemia, Sickle Cell

Other Conditions

Sickle Cell Disease

Stopping Reasons

The safety and efficacy of plerixafor in adult and pediatric SCD patients was an unknown when we started. A lot more data from therapeutic trials is available. We feel that recruiting patients without a therapeutic option isn't ethically justifiable.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID